DEPC [1609-47-8]

Pedido mínimo 3

Referencia NB-64-35112-1ml

embalaje : 1mLx10mM(inDMSO)

Marca : Neo Biotech

Contact local distributor :


Teléfono : +1 850 650 7790

DEPC (Synonyms: Diethyl pyrocarbonate)

Catalog No. T65118 Copy Product Info
Purity: 99.30%
DEPC (Diethyl pyrocarbonate) is a potent and irreversible RNase inhibitor containing histidine residues.DEPC can be used to prevent RNA enzyme degradation by modifying histidine residues with carboxylation resulting in enzyme inactivation. DEPC showed inhibitory effect on the central chemical sensitivity of rabbits. DEPC modified His, Tyr, Ser and Thr residues.

DEPC

Copy Product Info
Synonyms Diethyl pyrocarbonate

DEPC (Diethyl pyrocarbonate) is a potent and irreversible RNase inhibitor containing histidine residues.DEPC can be used to prevent RNA enzyme degradation by modifying histidine residues with carboxylation resulting in enzyme inactivation. DEPC showed inhibitory effect on the central chemical sensitivity of rabbits. DEPC modified His, Tyr, Ser and Thr residues.

DEPC
Cas No. 1609-47-8
Select Batch
Purity:99.30%
Appearance:Liquid
Color:Transparent
Contact us for more batch information

Product Introduction

Bioactivity
Description
DEPC (Diethyl pyrocarbonate) is a potent and irreversible RNase inhibitor containing histidine residues.DEPC can be used to prevent RNA enzyme degradation by modifying histidine residues with carboxylation resulting in enzyme inactivation. DEPC showed inhibitory effect on the central chemical sensitivity of rabbits. DEPC modified His, Tyr, Ser and Thr residues.
In vivo
Insulin binding to rat liver plasma membranes is inhibited in a time- and dose-dependent fashion by prior treatment of membranes with the histidine-specific reagent diethyl pyrocarbonate.[1]
SynonymsDiethyl pyrocarbonate
Chemical Properties
Molecular Weight162.14
FormulaC6H10O5
Cas No.1609-47-8
SmilesCCOC(=O)OC(=O)OCC
Storage & Solubility Information
StoragePure form: -20°C for 3 years | In solvent: -80°C for 1 year
Solubility Information
DMSO: 55 mg/mL (339.21 mM), Sonication is recommended.
H2O: 30 mg/mL (185.03 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween-80+45% Saline: 5 mg/mL (30.84 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
H2O/DMSO
1mg5mg10mg50mg
1 mM6.1675 mL30.8375 mL61.6751 mL308.3755 mL
5 mM1.2335 mL6.1675 mL12.3350 mL61.6751 mL
10 mM0.6168 mL3.0838 mL6.1675 mL30.8375 mL
20 mM0.3084 mL1.5419 mL3.0838 mL15.4188 mL
50 mM0.1234 mL0.6168 mL1.2335 mL6.1675 mL
100 mM0.0617 mL0.3084 mL0.6168 mL3.0838 mL
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density.